These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 34686406)

  • 21. Longitudinal analysis of atherosclerotic cardiovascular disease risk and healthcare costs in newly diagnosed type 2 diabetes in a real-world setting.
    Weng W; Liang Y; Brett J; Hobbs T; Baeres FMM
    J Diabetes Complications; 2020 May; 34(5):107500. PubMed ID: 32173216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of type 2 diabetes mellitus in children and adolescents.
    Springer SC; Silverstein J; Copeland K; Moore KR; Prazar GE; Raymer T; Shiffman RN; Thaker VV; Anderson M; Spann SJ; Flinn SK;
    Pediatrics; 2013 Feb; 131(2):e648-64. PubMed ID: 23359584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linagliptin in patients with type 2 diabetes and cardiovascular and/or renal disease: results from a cardiovascular and renal outcomes trial.
    Guthrie R
    Postgrad Med; 2020 May; 132(4):314-319. PubMed ID: 32164494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data.
    Young JB; Gauthier-Loiselle M; Bailey RA; Manceur AM; Lefebvre P; Greenberg M; Lafeuille MH; Duh MS; Bookhart B; Wysham CH
    Cardiovasc Diabetol; 2018 Aug; 17(1):118. PubMed ID: 30143045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes & Women's Health (DWH) Study: an observational study of long-term health consequences of gestational diabetes, their determinants and underlying mechanisms in the USA and Denmark.
    Zhang C; Olsen SF; Hinkle SN; Gore-Langton RE; Vaag A; Grunnet LG; Yeung EH; Bao W; Bowers K; Liu A; Mills JL; Sherman S; Gaskins AJ; Ley SH; Madsen CM; Chavarro JE; Hu FB;
    BMJ Open; 2019 May; 9(4):e025517. PubMed ID: 31048434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of comorbidities on glycemic control among Colombian adults with diabetes mellitus: a longitudinal approach with real-world data.
    Urina-Jassir M; Herrera-Parra LJ; Hernández Vargas JA; Valbuena-García AM; Acuña-Merchán L; Urina-Triana M
    BMC Endocr Disord; 2021 Jun; 21(1):128. PubMed ID: 34174843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Joint and distinct risk factors associated with micro- and macrovascular complications in a cohort of type 2 diabetic patients cared through disease management.
    Ciardullo AV; Daghio MM; Bevini M; Feltri G; Novi D; Fattori G; Borsari S; Donato CD
    Acta Diabetol; 2010 Dec; 47(4):301-8. PubMed ID: 20383650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships between lifestyle patterns and cardio-renal-metabolic parameters in patients with type 2 diabetes mellitus: A cross-sectional study.
    Ogihara T; Mita T; Osonoi Y; Osonoi T; Saito M; Tamasawa A; Nakayama S; Someya Y; Ishida H; Gosho M; Kanazawa A; Watada H
    PLoS One; 2017; 12(3):e0173540. PubMed ID: 28273173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of diabetes-associated secondary healthcare utilization between alternative oral antihyperglycaemic dual therapy combinations with metformin in patients with type 2 diabetes: an observational cohort study.
    Strongman H; D'Oca K; Langerman H; Das R
    Diabetes Obes Metab; 2015 Jun; 17(6):573-580. PubMed ID: 25735201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychological risk factors of micro- and macrovascular outcomes in primary care patients with type 2 diabetes: rationale and design of the DiaDDZoB Study.
    Nefs G; Pouwer F; Denollet J; Pop VJ
    BMC Public Health; 2010 Jul; 10():388. PubMed ID: 20594337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Chronic Kidney Disease in Type 2 Diabetes: The Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study.
    Chu L; Fuller M; Jervis K; Ciaccia A; Abitbol A
    Clin Ther; 2021 Sep; 43(9):1558-1573. PubMed ID: 34426012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH; Sapir T
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of morning home blood pressure measurements in patients with type 2 diabetes mellitus: results of a 10-year, prospective, longitudinal study.
    Kamoi K
    Clin Exp Hypertens; 2015; 37(2):122-7. PubMed ID: 24786228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes.
    Handelsman Y
    Adv Ther; 2019 Oct; 36(10):2567-2586. PubMed ID: 31444707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations.
    Deerochanawong C; Chan SP; Matawaran BJ; Sheu WH; Chan J; Man NH; Suastika K; Khoo CM; Yoon KH; Luk A; Mithal A; Linong J
    Diabetes Obes Metab; 2019 Nov; 21(11):2354-2367. PubMed ID: 31264765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using electronic health record data for substance use Screening, Brief Intervention, and Referral to Treatment among adults with type 2 diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network study.
    Wu LT; Brady KT; Spratt SE; Dunham AA; Heidenfelder B; Batch BC; Lindblad R; VanVeldhuisen P; Rusincovitch SA; Killeen TK; Ghitza UE
    Contemp Clin Trials; 2016 Jan; 46():30-38. PubMed ID: 26563446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus.
    Cherney DZI; Repetto E; Wheeler DC; Arnold SV; MacLachlan S; Hunt PR; Chen H; Vora J; Kosiborod M
    Am J Nephrol; 2020; 51(1):74-82. PubMed ID: 31812955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing risk of future cardiovascular events, healthcare resource utilization and costs in patients with type 2 diabetes, prior cardiovascular disease and both.
    Nguyen C; Luthra R; Kuti E; Willey VJ
    Curr Med Res Opin; 2020 Dec; 36(12):1927-1938. PubMed ID: 33023310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose, cholesterol and blood pressure in type II diabetes: A longitudinal observational study comparing patients with and without severe mental illness.
    Smith R; Han L; Ali S; Prady SL; Taylor J; Hughes T; Ajjan RA; Siddiqi N; Doran T
    J Psychiatr Ment Health Nurs; 2019 Nov; 26(9-10):347-357. PubMed ID: 31287193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.